Activated PEGs for PEGylation
Top > Advantages of NOF > PEGylation Reference
PEGylation Reference
Following figure shows several examples of PEG-aldehyde conjugation with human insulin for various molecular weights of PEG.
Analysis of PEG-ALD-Insulin by SDS-PAGE with Coomassie brilliant blue.
Insulin was reacted with NOF PEG-ALD at 4. The PEGylaed insulin was purified on Q Sepharose Fast Flowcolumn.
| lane M molecular weight markers | lane 3 PEG(ME-100AL)-insulin eluate |
| lane 1 insulin | lane 4 PEG(ME-200AL)-insulin eluate |
| lane 2 PEG(ME-050AL)-insulin eluate | lane 5 PEG(ME-300AL)-insulin eluate |
- Coupling of PEG-NHS derivatives to protein amines (PEG-NHS + Protein-NH2) Conditions 1: 50 mM phosphate buffer (pH 7.2), 4, 6 hr*1)
Conditions 2: Borate-phosphate buffer (pH 8.0), 25, 2 hr*2) - Coupling of PEG-Aldehyde derivatives to the NH2 group of proteins (PEG-Ald + Protein-NH2)
Conditions : sodium cyanoborohydride (10 equiv.), 4, 20 hr*3) - Coupling of PEG-Maleimide derivatives to the SH group of proteins (PEG-Maleimide + Protein-SH)
Conditions: 100 mM phosphate buffer (pH 6.5), 4, 4 hr - Coupling of PEG-NH2 derivatives to the COOH group of proteins (PEG-NH2 + Protein-COOH)
Conditions: 50mM phosphate buffer (pH 7.2), WSC (2 equiv.), 4, 10 hr - Coupling of PEG-p-Nitrophenyloxycarbonyl derivatives to the NH2 group of proteins (PEG-NP + Protein-NH2)
Conditions: borate-phosphate buffer (pH 8.0-8.3), rt, overnight*2)
*1) Abuchowski, A., et al. (1984) Cancer Biochem. Biophys. 7, 175.
*2) Sartore, L., et al. (1991) Appl. Biochem. Biotechnol. 27, 45
*3) US 5,824,784
